It is typically measured using the body mass index (BMI), a calculation that considers both weight and height
Sources ---------------------- -----------------------------
"A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models"
Vyndaqel (tafamidis) Disease area(s): Cardiovascular/Rare disease Manufacturer(s): Pfizer 2024 Sales (USD): $5.45 billion Why it sold so well: In 2024, Pfizers Vyndaqel family (including Vyndaqel, Vyndamax and Vynmac) achieved significant sales growth, with global revenues increasing by 60% year-over-year
Thay v s dng ng ung thng thng, cng ngh ngm di li ang c nhiu ngi u tin nh kh nng hp thu hiu qu
In the first trial, lixisenatide 20 g QD (n = 46) and liraglutide 1.2 (n = 44) and 1.8 mg QD (n = 46) were compared following 8 weeks treatment in 142 subjects with T2DM not adequately controlled with insulin glargine with or without metformin [17]